Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global exosomes market 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Region trends
2.1.3 Products & services trends
2.1.4 Application trends
2.1.5 Indication trends
2.1.6 End-users trends
Chapter 3 Exosomes Market Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing technological advancements in exosome isolation
3.2.1.2 Rising government and non-government initiatives for exosome research
3.2.1.3 Increasing prevalence of cancer
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of standardization
3.2.2.2 Ethical & privacy concerns
3.3 Growth potential analysis
3.3.1 By products & services
3.3.2 By application
3.3.3 By indication
3.3.4 By end-users
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Exosomes Market Estimates and Forecast, By Products & Services, 2018 - 2032 (USD Million)
5.1 Key trends, by products & services
5.2 Kits & reagents
5.2.1 Antibodies
5.2.2 Isolation, purification, quantitation kits & reagents
5.2.3 Other kits & reagents
5.3 Instruments
5.4 Services
Chapter 6 Exosomes Market Estimates and Forecast, By Application, 2018 - 2032 (USD Million)
6.1 Key trends, by application
6.2 Diagnostic
6.3 Therapeutic
Chapter 7 Exosomes Market Estimates and Forecast, By Indication, 2018 - 2032 (USD Million)
7.1 Key trends, by indication
7.2 Cancer
7.3 Neurodegenerative diseases
7.4 Cardiovascular diseases
7.5 Infectious diseases
7.6 Other indications
Chapter 8 Exosomes market Estimates and Forecast, By End-users, 2018 - 2032 (USD Million)
8.1 Key trends, by end-users
8.2 Pharmaceutical & biotechnology companies
8.3 Hospitals & diagnostics centers
8.4 Academic & research institutes
Chapter 9 Exosomes Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.2 Bio-Techne Corp
10.3 QIAGEN
10.4 Beckam Coulter (Danaher Corp)
10.5 Diagenode (Hologic Inc)
10.6 Lonza
10.7 Abcam
10.8 RoosterBio, Inc.
10.9 Miltenyi Biotec
10.10 Fujifilm Holdings Corp.
10.11 Hitachi Chemical Diagnostics Inc.
10.12 Clara Biotech
